{"name":"Seoul Pharma Co., Ltd.","slug":"seoul-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPRTdKdlVXa3BDdXMyaXplYmJvZzJ6S20zUTYzcFR5SURzVVdJaUxKVGJkVDhTWHFZN3pSZ0xTN0RNQ1h6N1V3YmtSR0FRZ0RabmI0Z21VTTAwNkxDVGJJYTlGaFdPdHY0LXJ5cDVHSW41TnVjMlJpaWdIZGM5dHE2WElDUGFJcl9BMjA4OEpoX2luaUkycml3?oc=5","date":"2026-03-05","type":"pipeline","source":"BioWorld News","summary":"Roche to invest ₩710B in South Korea over five years - BioWorld News","headline":"Roche to invest ₩710B in South Korea over five years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxORldZSVEzb0phenhtcHN3Xy14OUhJeFZEc1lwVmxGdXFJY1JXSEtGbEQyWkdEOElObDFKcEktN0xGdjhqUkFuWm5RT0FnVnZwNzc4TmpLblgtd1k5d2w1bzlSQmJFZkRKazg4aFl0TUoxdDJDbEtudGZBUF9JMDZpUVVSdXIxT3BFRy1NLXVVRUVfWjVmbzBKYXEyMVNmU0o1ZDRPWjdKaWdVS3FtbFFwWi1vYlBucEZXSUs5U2NVNE5CT2VFMzZzZ1VIeGhIMnJZdzVvQmZEN2Q5b0Z0bXBLZ1pqR0pMbngxWmIyY3BTODB4Zw?oc=5","date":"2026-03-04","type":"pipeline","source":"GlobeNewswire","summary":"Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea - GlobeNewswire","headline":"Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBRWnQ2OEUxWDhTcW1rVEtHS0NQbjI1SEdsTUpTU3dJeTNyaFRVTzRGbzhPWXBuYlhmOWQ0Z1NwNWlRSVpTMEJPb3VzVkpwNzROYjc0WEh6aHdJYmVqQ3VIZ3J3TTg2UjFWd0hPY0Rn?oc=5","date":"2026-02-03","type":"pipeline","source":"KED Global","summary":"Korea's Medipost, success story of tech-focused private equity firms Crescendo, Skylake - KED Global","headline":"Korea's Medipost, success story of tech-focused private equity firms Crescendo, Skylake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgNBVV95cUxPdUtoUkZscEVqbV9xeFdmTUZ6VzJRbGUwWmx1SDVyZmtYTl9CQ3BQaVFQd21mZ0RYa3RDNmVLc1BPNEVIOWRvNzc4a25SVjNUT21VOWd5WXNRYkFOYWFxTjNjb2F0ZGl0akxWVmtVNlA3eDAtVnc4MHRyZFhBa1hqbDNPa2N2LVlMQ2QxOU9vd0VHNUpXLUZTRi1uWDhGM0RnenJ0bm5jREQyMTZPdXJVcWRUaWtDVDhqRDV0VHp2aWZzV3p4V3QwZC0zbWFSaElUWHF6eWNhRTBNbVVHTXhZdjU3Sk9GZU9rQzZ4eFlsZzJ2U3NMaFpqNDYyalNxdV90OWdjNmxlZ2FIYklOQTM2NGZKUEtKN1piVENqYnNlb2diMmpMSGFfcVFNUUFDN2pGNFcxcVFVdjgtXzI1Q0lJbmpaV1JXMjJIaGstR0NTSE1YRTFLVlhNSHVlT0kycmp0clpId0Y2S0g3Tjh5MjZpbnJseXpfV3BOMlFzX3R1Rk1rUl9XZWJRcDZtRFR4NER1Vmc?oc=5","date":"2026-01-12","type":"pipeline","source":"PR Newswire","summary":"Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and P","headline":"Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNTWdSMGVrMDJFT0NiQlhYN1RyeEt3dnA3eXJwdllNa2tnb3hHbTFQRzFUWXF6UGZNc0pqMV9pT3pZUXY5Z3RIc1VrM2hIQTJycU50Tkc3MTM3S3lRaFNMOUJlSUVYWDRNelQ1a1E3QjNxd0FESmJMZUJqTHBrUmNnVtIBlAFBVV95cUxOeFBZZGN1NWdpOWJzeXFqaHpxY21HTER2UlFJN0hvUWRSS0dZcnNhcThlMlNHajNtSVRSVEhvN0ZKSmFmZ2c0OGxpYnF1Vkh4blRnTTg5WnQwRUh3SnN5TG9yNWdKeVlFSjBoUDRyOUh6RmsxNGpaOXpsWDFFNnFiSU5keW9aTEY4OEwxaURZWm5DTnJr?oc=5","date":"2025-12-30","type":"pipeline","source":"Chosunbiz","summary":"Nam Tae-hoon assumes vice chair and steers Kukje Pharma toward ophthalmology growth - CHOSUNBIZ - Chosunbiz","headline":"Nam Tae-hoon assumes vice chair and steers Kukje Pharma toward ophthalmology growth - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBEOFdCcTBLSGFvX05xdUUwMElkSEZYNjNGYnJQV3liWWdrX2tTRlJFaUllbVl2RjBkSkVUaG9uQjFTeHd6LWpqUzgxTDZzZmJPQnpOWk9fM2lXTVJlWTVaamJvVHo?oc=5","date":"2025-11-05","type":"pipeline","source":"아시아경제","summary":"Korea Pharmaceutical and Bio-Pharma Association Selected as Lead Institution for 'K-AI Preclinical and Clinical Model Development Project' - 아시아경제","headline":"Korea Pharmaceutical and Bio-Pharma Association Selected as Lead Institution for 'K-AI Preclinical and Clinical Model De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOMVJSeUd1ZjdmOWs5ZGhHY29FX0o0eUdTUm1JOTcxV2FDRG5TMHM3NHRDdTFvZ01Ta0F3T2J0dXdHTWRteXA5OEpFS1VYdWRaWEthUm16WFpFNnlaSHFfOC1oUTBnaDZrc3NlWktuSzhrYktuUkQ3NXNJN0FqZkxCdNIBlAFBVV95cUxQb3dFa2tlelFjSWhHZ2ItUktiV0NVdm9hdjVnLWktTzJqSG5JXzlmZDU2c0JWN1JSajFFV0hhSnBJQUhVNnZOaWk2WGtRYmh6blJKNDNHQ2hyQ29MRmRwcnctNkIwZ1JwYmw1b1JvbEhEY2R0bFhVUEJqQWRRSVhPLVBkM29pMVI4eVBnUF9Oa2htWXBO?oc=5","date":"2025-10-28","type":"pipeline","source":"Chosunbiz","summary":"Samik Pharm hits daily upper price limit on second day after KOSDAQ listing - CHOSUNBIZ - Chosunbiz","headline":"Samik Pharm hits daily upper price limit on second day after KOSDAQ listing - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOVlNJQ2ttSjhmZFdtcGstdUVRaFdnVUFWbFJmeThBWF9Ma2tJR2pkTE1FV3BTNUJfZm9wOXJWd0lwMjlvbVNUSXJyS0kwS2ZOT2xrS196bUpfVDRMa2E4b0pTQmxDaUc4ek1BOUlINGpHRHgzcm9OQlFUVzhTZ3o1NmZBd3VSanBHUUtTU0NMa2MzZlZnOVVERU5oYnVKdmxIcUtscXJ5WkRtMUZHcl8wdXRNcTZvN0t6ckNMbW1R?oc=5","date":"2025-09-15","type":"deal","source":"Ocugen, Inc.","summary":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - Ocugen, Inc.","headline":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPeG9WX09ZU000MUV2U2JtSmRjenpRd1N6RmNZQTNtU1l0cnFJS28xWVJOdVJ2S3BVcnlUNXBGTkxUM0FEN1E5NHRYX1VYWkRfcVZmZ0dwcWtWX2xpa0p5R0F1WXlSdUNiUXZrekFpWktiZFZsX2drY0JsMjFtdlRwMGJVdmRhbkhoN3ByWjFhVl9ZS1ZNanV6UkdzQ0dqUzJCR0wzTHE3enY?oc=5","date":"2025-07-29","type":"pipeline","source":"BioWorld News","summary":"South Korea hits record $23B pharma production; 2024 exports up 28% - BioWorld News","headline":"South Korea hits record $23B pharma production; 2024 exports up 28%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPeGdReTNPZ09XcktqY2V6d1FpSEt2NEk5RWVUdGdRQWJJMThVSDNCcEdCWmE5WlJwZnJGbVhUUmM1UDcwN2VDY3BqYUxPbnBRWjE0QXhlVGg4MUpHOTlkZlVYQ05tbWg3OGxYYzA3TWpRRnZZMnRaYmxnQVMxc2NRd1RrbVQ3cVE?oc=5","date":"2025-07-28","type":"deal","source":"Yahoo Finance","summary":"South Korea's Celltrion says tapped to buy US pharma factory to offset tariff risk - Yahoo Finance","headline":"South Korea's Celltrion says tapped to buy US pharma factory to offset tariff risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPSk5tZ19XQ1lfMUxxLWlkNWYtMjR3NF92b2RfTmdBYlBBS2JUWXFpT0hKZVZCLS14VW9ka0tjODE2QnRjSTlOcGhybU9yY29KUnVhVFNpTVdXUmpqLVF1aGJvVmtEdHVfZ252S3JwZEg5aWtHeEdIdGpwcElhNFhldjlrMXZMSnNVckZBZzdDdTFHMlZ1OTFmWjhRZ0NmUl93SXctLWhmQjlsdElHRnFrbjRjVk1mMlhLRW9iSFlxUjJIenF4bENzaWZxWEUzNW83LUQta0FQTjRzeFFTYVRVWGVSbzBnTWc1bEFvQWx4MlJ5UUUzMFRxSGVwVnpxbHloLURyelNoTnNZZHdPZ2trczVPNjNHbWtnbXNsc3F0bGdKdm16dkl6b3NhbUNwZzlOV1g5WXIyQWsxZjhw?oc=5","date":"2025-05-09","type":"deal","source":"LENZ Therapeutics","summary":"LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia - LENZ Therapeutics","headline":"LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOazQ3NTZ2cXN3Z3hydmdxS2Q3NWl1UjNsNEd0UmlucWRSbElFLUdVTjhSMmp4VkN6S0N4MEE5cmN0NUdNU3JENGQwX2lLUzhvNkhMMmJGOUFfQUpGc29MWS1wYl9rZzk0MnZ6ZWxjbHVKNno1SXpXcURpZDJJTzExSGM2eVVqRDlISWxpZmVndlo0bktrQ0E?oc=5","date":"2020-12-14","type":"deal","source":"Pharmaceutical Technology","summary":"South Korea: biologics production and Covid-19 deals boost bio/pharma industry - Pharmaceutical Technology","headline":"South Korea: biologics production and Covid-19 deals boost bio/pharma industry","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}